Dr. Michael Rieder
Rieder joined the Department of Paediatrics and Children's Hospital in 1985. He obtained his MD at the University of Saskatchewan in 1980 and his Ph.D.
at the University of Toronto in 1992. His paediatric resident training was at the Children's Hospital of Michigan and he completed fellowships in Paediatric Clinical Pharmacology and Paediatric Emergency Medicine at the Hospital for Sick Children in Toronto.Dr.
Rieder is a Professor with the Department of Paediatrics, Physiology and Pharmacology and Medicine at Schulich Medicine & Dentistry, Western University. He is the Head of the Division of Paediatric Clinical Pharmacology and is a Scientist at the Robarts Research Institute. He is a member of the Drug Therapy Committee of the Canadian Paediatric Society and is a member of the Executive of the Canadian Society of Pharmacology and Therapeutics. He has served as a consultant to Health Canada, the NIH, the MRC and the Canadian College of Academies. Dr.
Rieder's research focuses on drug safety and adverse drug reactions as well as on optimal therapeutics in children. This includes studying genetic variations and their impact on drug efficacy and safety and the mechanisms of drug hypersensitivity. As well, Dr.
Rieder's laboratory has developed a number of novel assays for the assessment for drug and food safety.Dr.
Rieder has been the recipient of many awards including the 1994 and 1996 Young Investigator of the Year for the Canadian and American Societies of Clinical Pharmacology, the Senior Investigator Award of the Canadian Society of Clinical Pharmacology and the Academic Leadership Award in Clinical Investigation from the Paediatric Chairs of Canada. Other distinguished awards include the Harvard Macy Scholar Award, the Douglas Bocking Award, several Teacher of the Year Awards, Fellowships from the Royal Colleges of Physicians and Surgeons of Glasgow and Edinburgh, a Distinguished University Professor award at Western and the Yaffe Lifetime Achievement Award from the Pediatric Pharmacy Advocacy Group. He holds the CIHR-GSK Chair in Paediatric Clinical Pharmacology, the only endowed Chair in Paediatric Clinical Pharmacology in Canada.